Riskpilot← Back to searchSign inGet full accessDermaKnowlogy ApS
APSActiveCVR 10055318Europavej 10Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2000— employees
Revenue 2024
DKK -885K
+20% vs 2023
EBITDA margin
100.0%
-20% vs 2023
Equity ratio
-384.1%
Financial strength
Net profit 2024
DKK -882K
+3% vs 2023
| Revenue | DKK -885K | +20% |
| EBITDA | DKK -885K | -20% |
| Net profit | DKK -882K | +3% |
| Total assets | DKK 1,6M | +92% |
| Equity | DKK -6,3M | -16% |
| Employees | — | — |
Legal name
DermaKnowlogy ApS
CVR number
10055318
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
20. november 2000
Share capital
DKK 126.000
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsens formand i forening med direktøren.
Company purpose
Selskabets formål er at drive virksomhed med handel af hudplejemidler og helseartikler, import, eksport og anden efter direktionens skøn i forbindelse hermed beslægtet virksomhed.
Address
Europavej 10
Phone
+4586477744
Email
info@dermapharm.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 758 | 913 | -172 | -4 | -6 | -287 | -538 | -1.685 | -559 | -654 | -920 | -737 | -885 |
| Staff expenses | -688 | -464 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 70 | 449 | -172 | -4 | -6 | -287 | -538 | -1.685 | -559 | -654 | -920 | -737 | -885 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -15 | -107 | -120 | -96 | -96 | -93 | -25 |
| EBIT | 70 | 449 | -172 | -4 | -6 | -287 | -553 | -1.792 | -679 | -750 | -1.016 | -830 | -910 |
| Net financials | -64 | -55 | -2 | -2 | -3 | -9 | -55 | -117 | -148 | -164 | -208 | -210 | -221 |
| Profit before tax | 6 | 395 | -173 | -6 | -9 | -296 | -608 | -1.909 | -827 | -915 | -1.225 | -1.041 | -1.131 |
| Tax | 2 | 109 | 64 | 33 | -3 | -65 | -132 | -417 | -186 | -201 | -269 | -132 | -249 |
| Net profit | 4 | 286 | -237 | -39 | -6 | -231 | -475 | -1.492 | -641 | -714 | -955 | -908 | -882 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2.213 | 1.098 | 177 | 71 | 74 | 671 | 2.026 | 1.614 | 834 | 1.158 | 1.700 | 856 | 1.643 |
| Equity | -13 | 272 | 35 | -5 | -11 | -241 | -717 | -2.209 | -2.849 | -3.563 | -4.518 | -5.426 | -6.309 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2.226 | 826 | 142 | 75 | 85 | 853 | 2.645 | 3.728 | 3.615 | 4.673 | 6.218 | 6.283 | 7.951 |
| Total debt | 2.226 | 826 | 142 | 75 | 85 | 853 | 2.645 | 3.728 | 3.615 | 4.673 | 6.218 | 6.283 | 7.951 |
EBITDA margin
-88529100.0%
This company
15.8%
Market median
-560310859% vs market
20122024
Equity ratio
-384.1%
This company
38.2%
Market median
-1105% vs market
20122024
Return on equity
-88203600.0%
This company
18.4%
Market median
-479367491% vs market
20122024
Net profit margin
-88203600.0%
This company
8.1%
Market median
-1088933433% vs market
20122024
Asset turnover
-0.54×
This company
1.12×
Market median
-148% vs market
20122024
Debt / equity
1.26×
This company
0.62×
Market median
-103% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PB Management | Management | 2013 | — | — |
PB Management | Management | 2000 | — | — |
MJ Management | Management | 2001 | — | — |
TV Management | Management | 2001 | — | — |
HA Audit | Audit | 2000 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2011 | — | — | |
| Board of Directors | 2013 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2004 | — | — | |
| Board of Directors | 2011 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
DERMA PHARM A/S | Company | 66.7% | 66.7% | 2023 |
Uffe Koppelhus Holding ApS | Company | 25.0% | 25.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Uffe Koppelhus Holding ApS
DermaKnowlogy ApS Board members of DermaKnowlogy ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Bogh | Management | 0 companies |
| Preben Bang Henriksen | Management | 0 companies |
| Michael Jan Larsen | Management | 0 companies |
| Torben Villy Villadsen Kristensen | Management | 0 companies |
| Harry Aamann | Audit | 0 companies |
| Mikkel Egelund Jensen | Chairman | 0 companies |
| Birger Kuntkes | Board of Directors | 0 companies |
| Uffe Koppelhus | Board of Directors | 0 companies |
| Niels Jørgen Winther Christiansen | Board of Directors | 0 companies |
| Morten Guldberg | Board of Directors | 0 companies |